Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.18 | -$0.17 | -$0.17 |
| Q2 2026 | 1 | $0.08 | $0.08 | $0.08 |
| Q3 2026 | 1 | $0.09 | $0.10 | $0.09 |
| Q4 2026 | 1 | $0.08 | $0.09 | $0.09 |
| Q1 2027 | 1 | $0.25 | $0.27 | $0.26 |
| Q2 2027 | 1 | $0.45 | $0.48 | $0.47 |
| Q3 2027 | 1 | $0.41 | $0.44 | $0.43 |
| Q4 2027 | 1 | $0.38 | $0.40 | $0.39 |
| Q1 2028 | 1 | $0.05 | $0.05 | $0.05 |
| Q2 2028 | 1 | $0.47 | $0.50 | $0.49 |
| Q3 2028 | 1 | $0.43 | $0.46 | $0.45 |
| Q4 2028 | 1 | $0.54 | $0.58 | $0.56 |
Exact Sciences Corp. last posted its earnings results on Friday, February 13th, 2026. The company reported $-0.45 earnings per share for the quarter, missing analysts' consensus estimates of $-0.10793 by $0.34207. The company had revenue of 878.38 M for the quarter and had revenue of 3.25 B for the year. Exact Sciences Corp. has generated $-1 earnings per share over the last year ($-1.1 diluted earnings per share) and currently has a price-to-earnings ratio of -95.72. Exact Sciences Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/13/2026 | Q4 2025 | -$0.11 | -$0.45 | -0.34 | $860.90 M | $878.38 M |
| 11/03/2025 | Q3 2025 | -$0.06 | -$0.10 | -0.04 | $810.51 M | $850.74 M |
| 08/06/2025 | Q2 2025 | -$0.02 | -$0.01 | 0.01 | $773.77 M | $811.09 M |
| 05/01/2025 | Q1 2025 | -$0.37 | -$0.54 | -0.17 | $688.65 M | $706.79 M |
| 02/19/2025 | Q4 2024 | -$0.29 | -$4.67 | -4.38 | $702.21 M | $713.42 M |
| 11/05/2024 | Q3 2024 | -$0.20 | -$0.21 | -0.01 | $716.80 M | $708.66 M |
| 07/31/2024 | Q2 2024 | -$0.37 | -$0.09 | 0.28 | $690.02 M | $699.26 M |
| 05/08/2024 | Q1 2024 | -$0.47 | -$0.60 | -0.13 | $627.35 M | $637.52 M |
| 02/21/2024 | Q4 2023 | -$0.53 | -$0.27 | 0.26 | N/A | $646.89 M |
| 11/01/2023 | Q3 2023 | -$0.48 | $0.00 | 0.48 | N/A | $628.34 M |
| 08/01/2023 | Q2 2023 | -$0.50 | -$0.45 | 0.05 | N/A | $622.09 M |
| 05/09/2023 | Q1 2023 | -$0.79 | -$0.42 | 0.37 | N/A | $602.45 M |
| 02/21/2023 | Q4 2022 | -$0.90 | -$0.72 | 0.18 | N/A | $553.00 M |
| 11/03/2022 | Q3 2022 | -$1.10 | -$0.84 | 0.26 | N/A | $523.07 M |
| 08/02/2022 | Q2 2022 | -$1.07 | -$0.94 | 0.13 | N/A | $521.64 M |
| 04/26/2022 | Q1 2022 | -$1.12 | -$1.04 | 0.08 | N/A | $486.57 M |
| 02/22/2022 | Q4 2021 | -$0.91 | -$1.28 | -0.37 | N/A | $473.81 M |
| 11/02/2021 | Q3 2021 | -$0.89 | -$0.97 | -0.08 | N/A | $456.38 M |
| 07/28/2021 | Q2 2021 | -$0.72 | -$1.03 | -0.31 | N/A | $434.82 M |
| 05/04/2021 | Q1 2021 | -$1.04 | -$0.18 | 0.86 | N/A | $402.08 M |
The conference call for Exact Sciences Corp.'s latest earnings report can be listened to online.
The conference call transcript for Exact Sciences Corp.'s latest earnings report can be read online.
Exact Sciences Corp. (:EXAS) has a recorded annual revenue of $3.25 B.
Exact Sciences Corp. (:EXAS) has a recorded net income of $-207,949,000.Exact Sciences Corp. has generated $-1.1 earnings per share over the last four quarters.
Exact Sciences Corp. (:EXAS) has a price-to-earnings ratio of -95.72 and price/earnings-to-growth ratio is -1.09.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED